Vault-13

EIGER BIOPHARMACEUTICALS INC CLDN

COM NEW · Common Stock · CUSIP 28249U204

1 institutional holders +0 vs Q1 2025
146,381146.4k shares reported held*
$423.0kreported value*
0 new 0 added 0 reduced 0 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.89.

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

0102030Q1 24: 25Q2 24: 2Q3 24: 1Q4 24: 1Q1 25: 1Q2 25: 11Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25
Numbers
QuarterHolders
Q1 202425
Q2 20242
Q3 20241
Q4 20241
Q1 20251
Q2 20251

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q2 24: 0 bought or addedQ2 24: 24 cut or sold outQ2 24Q3 24: 0 bought or addedQ3 24: 1 cut or sold outQ3 24Q4 24: 0 bought or addedQ4 24: 0 cut or sold outQ4 24Q1 25: 0 bought or addedQ1 25: 0 cut or sold outQ1 25Q2 25: 0 bought or addedQ2 25: 0 cut or sold outQ2 25
Numbers
QuarterBought or addedCut or sold out
Q2 2024024
Q3 202401
Q4 202400
Q1 202500
Q2 202500

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Propel Bio Management, LLC 0.51% of their portfolio Los Angeles, CA 146,381146.4k $423.0k $423.0k 0.51% Unchanged